NCT00533988View on ClinicalTrials.gov

Central Venous Catheter-Related Infection

PHASE4CompletedINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

January 31, 1996

Study Completion Date

December 31, 1999

Conditions

Critically Ill PatientsInfection

Interventions

DEVICE

Antimicrobial impregnated catheter (5593)

Comparison of 14-day placement of a standard triple lumen (ARROW Standard Triple Lumen Catheter, Arrow International Inc., Reading, PA, US) versus an antimicrobial impregnated catheter (Chlorhexidine-silver sulfadiazine)(ARROWgard Triple Lumen Catheter, Arrow International Inc., Reading, PA, US)

All Listed Sponsors

lead

University of Witwatersrand, South Africa

OTHER

NCT00533988 - Central Venous Catheter-Related Infection | Biotech Hunter | Biotech Hunter